Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$36.28

-1.01 (-2.71%)

13:55
11/29/16
11/29
13:55
11/29/16
13:55

Baird says doctor response to Sarepta DMD drug could mean strong launch

Doctors in the Duchenne muscular dystrophy field are taking to Sarepta's (SRPT) Exondys 51 despite its controversial, data-light approval path, a survey conducted by Baird revealed today, leading the research firm to argue that average estimates for the drug's first quarter on the market "feel light." BAIRD SURVEY INDICATES STRENGTH: After surveying 30 neurologists treating Duchenne muscular dystrophy patients, Baird's Brian Skorney comes away confident in a "strong launch" for Sarepta's Exondys 51. The analyst notes that most of the surveyed doctors "seem convinced of the drug's efficacy," with 23% of respondents already having started prescriptions and another 58% planning to start in the next year. Skorney adds that use estimates through year end indicate that consensus sales expectations of $7.1M "may be understating" the drug's first quarter on the market, with the survey data suggesting $8M in sales and the analyst himself forecasting $11M. Notably, the doctors speaking to Skorney said only about 58% of their patients have been genotyped, appearing to confirm the 60% estimate put forth by Sarepta and indicating a potential new pool of patients eligible for Exondys and its targeting of the exon 51 genotype. PRICE ACTION: Shares of Sarepta are up 3% to $37.40 in afternoon trading.

SRPT Sarepta
$36.28

-1.01 (-2.71%)

10/27/16
FBCO
10/27/16
NO CHANGE
Target $68
FBCO
Outperform
Sarepta reimbursement concerns overdone, says Credit Suisse
Credit Suisse analyst Alethia Young believes Sarepta Exondys 51 reimbursement concerns are "quite overdone" and notes payer negotiation is inline with what the company has seen in other rare disease drugs launch. Young rates Sarepta an Outperform with a $68 price target.
10/27/16
WEDB
10/27/16
NO CHANGE
Target $72
WEDB
Outperform
Sarepta selloff overdone, says Wedbush
Wedbush analyst Heather Behanna said the selloff in Sarepta is overdone and recommends shares ahead of the Exondys 51 launch update in January. The analyst has an Outperform rating and a $72 price target on Sarepta shares.
11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.

TODAY'S FREE FLY STORIES

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Recommendations
Ichor Holdings analyst commentary  »

Ichor Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

IPSEY

Ipsen

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Hot Stocks
Ipsen: Onivyde+-FU/LV improved overall survival in Phase 3 study »

Ipsen Biopharmaceuticals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

$NSD

NASDAQ Market Internals

13:17
01/17/18
01/17
13:17
01/17/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
01/17/18
01/17
13:16
01/17/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$63.42

0.92 (1.47%)

13:15
01/17/18
01/17
13:15
01/17/18
13:15
Hot Stocks
Wells Fargo announces retirement of chief risk officer Mike Loughlin »

Wells Fargo & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACLS

Axcelis

$30.30

1.15 (3.95%)

, AMAT

Applied Materials

$54.50

1.05 (1.96%)

13:14
01/17/18
01/17
13:14
01/17/18
13:14
Recommendations
Axcelis, Applied Materials analyst commentary  »

Axcelis presentation an…

ACLS

Axcelis

$30.30

1.15 (3.95%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

13:12
01/17/18
01/17
13:12
01/17/18
13:12
Periodicals
Broadcom probed by FTC over negotiations with customers, WSJ reports »

The FTC is probing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLM

Sallie Mae

$11.47

-0.24 (-2.05%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Technical Analysis
Technical Earnings Preview: SLM Corp in middle of range before news »

Shares have been trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Hot Stocks
Apple announces new U.S. investments, sees $38B of repatriation taxes »

Apple announced a new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

13:05
01/17/18
01/17
13:05
01/17/18
13:05
General news
Treasury Action: early March bills continue to underperform »

Treasury Action: early…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

, FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

13:04
01/17/18
01/17
13:04
01/17/18
13:04
Periodicals
FoxNext acquires game developer Cold Iron Studios, Polygon says »

FoxNext Games, the video…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 07

    Feb

  • 07

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:02
01/17/18
01/17
13:02
01/17/18
13:02
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple breaking ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple sees investing over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple announces new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

UPS

UPS

$133.62

0.74 (0.56%)

13:00
01/17/18
01/17
13:00
01/17/18
13:00
Options
Notable call spread in UPS as shares deliver profits »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$56.35

0.11 (0.20%)

12:57
01/17/18
01/17
12:57
01/17/18
12:57
Technical Analysis
Technical Earnings Preview: Alcoa near 52-week high before news »

Ahead of earnings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

, BMWYY

BMW

$37.64

1.125 (3.08%)

12:51
01/17/18
01/17
12:51
01/17/18
12:51
Periodicals
BMW to offer CarPlay as subscription-based service next year, The Verge says »

BMW (BMWYY) plans to…

AAPL

Apple

$176.19

-0.9 (-0.51%)

BMWYY

BMW

$37.64

1.125 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

TBT

ProShares UltraShort 20+ yr Trsry

$34.72

-0.06 (-0.17%)

12:50
01/17/18
01/17
12:50
01/17/18
12:50
Options
Closing puts in the ProShares UltraShort Longer-term Bond ETF »

Closing puts in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:50
01/17/18
01/17
12:50
01/17/18
12:50
General news
U.S. equities extended their bounce »

U.S. equities extended…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

, BA

Boeing

$347.06

11.9016 (3.55%)

12:48
01/17/18
01/17
12:48
01/17/18
12:48
Periodicals
Embraer tells Bloomberg no guarantee Boeing talks with result in deal »

Embraer (ERJ), in an…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

BA

Boeing

$347.06

11.9016 (3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

ASML

ASML

$186.38

5.51 (3.05%)

, LRCX

Lam Research

$190.39

1.88 (1.00%)

12:46
01/17/18
01/17
12:46
01/17/18
12:46
Hot Stocks
ASML results pull semiconductor equipment maker shares higher »

Shares of semiconductor…

ASML

ASML

$186.38

5.51 (3.05%)

LRCX

Lam Research

$190.39

1.88 (1.00%)

KLAC

KLA-Tencor

$107.66

0.37 (0.34%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

TER

Teradyne

$46.51

1.2 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

BCS

Barclays

$11.01

0.045 (0.41%)

12:45
01/17/18
01/17
12:45
01/17/18
12:45
Periodicals
Barclays slashes up to 100 senior investment bank staff, Bloomberg says »

Barclays is cutting up to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

12:41
01/17/18
01/17
12:41
01/17/18
12:41
Technical Analysis
Technical Earnings Preview: Kinder Morgan in uptrend before results »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

FB

Facebook

$178.39

-0.98 (-0.55%)

12:41
01/17/18
01/17
12:41
01/17/18
12:41
Hot Stocks
Facebook initiates new probe into possible Russian meddling around Brexit vote »

Facebook's U.K.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

PSX

Phillips 66

$106.20

2.7 (2.61%)

12:40
01/17/18
01/17
12:40
01/17/18
12:40
Options
Notable call buying in Phillips 66 as shares see relative strength »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.